HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Dr Ronald Silverman Named BD Chief Medical Officer
Dr Ronald Silverman will be responsible for leading the company's Medical Affairs organization, which includes end-to-end medical affairs across BD's business units, regions and central team. In this role, he will use medical insights and expertise to advance BD's pipeline of clinically relevant, innovative solutions that align with evolving patient needs, while also contributing to the safety and compliance of BD's in-market portfolio of products.
Bill Hoffman Joins Magenta Medical’s Board of Directors
"Bill Hoffman is a widely respected and accomplished leader in the MedTech industry. The company is certain to benefit from his experience and insights as it looks to achieve its upcoming clinical milestones and future commercial goals," said Dr. David Israeli, CEO of Magenta Medical.
Cordis Announces Scott Drake as Chief Executive Officer
Scott Drake has over 30 years of medical device experience including as the President and CEO of the Spectranetics Corporation, where he increased shareholder value from approximately $170 million to $2.2 billion during his six-year tenure. He has served on numerous boards of directors, including Zayo Group Holdings, which Digital Colony and EQT (EQT) acquired for $14.3 billion, Paragon 28, Inc. (FNA), ViewRay (VRAYQ), Bolder Surgical, the Medical Device Manufacturers Association (MDMA), and he has served as the Chairman of Atricure, Inc. (ATRC).
TATAA Announces Formation of Scientific Advisory Board
TATAA notes the inaugural members of the SAB include Dr. Binodh DeSilva, Dr. Kaia Sartori, Dr. Lydia Michaut, Dr. Matthias Machacek, and Dr. Zain Kassam.
Jesse Neri Named Senior Vice President at Finance at Rockwell Medical
Jesse Neri has over 20 years' experience leading finance functions at both public and private companies. Prior to joining Rockwell Medical, he was the head of finance at Hemavant Sciences, a clinical stage biopharmaceutical company developing therapeutics to improve the lives of patients with blood disorders and hematological malignancies.
NovApproach Spine Elects Sigurd H. Berven, MD, to Board
NovApproach Spine CEO Raymond Cloutier reports, "Dr. Berven has been a chief contributor to the OneLIF cage's evolution. A world-renowned expert in treating spinal disorders, he brings clinical, research and academic perspectives that will strengthen our company's ability to deliver clinically relevant solutions. It's an honor to have his guidance during our company's rapid growth."
Arvin Yang, MD, PhD Appointed Chief Medical Officer of Pheon Therapeutics
Dr Arvin Yang brings extensive experience in leading early-stage clinical trials and late stage global registrational trials.
Closed Loop Medicine appoints Konstantinos Vlassis as Chief Technology Officer
Konstantinos Vlassis will oversee design and implementation of technology strategy, engineering resources and infrastructure to deliver corporate objectives.
Renowned Orthopedic Surgeon, Dr. Stephen Hochschuler, Joins Backstop Neural’s Advisory Board
Dr. Stephen Hochschuler is a distinguished figure in the medical field, renowned for his groundbreaking work in orthopedic surgery. With over four decades of experience, Dr. Hochschuler has consistently pushed the boundaries of medical science, contributing significantly to the advancement of surgical techniques and patient care.
